📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ustekinumab for severe atopic dermatitis: an important negative study. (2017)

First Author: Samuel RJ

Attributed to: MICA: The Newcastle Proximity Laboratory funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjd.15712

PubMed Identifier: 28833005

Publication URI: http://europepmc.org/abstract/MED/28833005

Type: Journal Article/Review

Volume: 177

Parent Publication: The British journal of dermatology

Issue: 2

ISSN: 0007-0963